October 10, 2026
Viatris to Buy Pacira BioSciences for .65 Billion




Viatris has agreed to buy pain-drug maker Pacira BioSciences for $1.65 billion in a deal that expands the healthcare company’s medicines portfolio.

About The Author

United State 24

See author's posts

Leave a Reply

Your email address will not be published. Required fields are marked *

Related News

Why Ford Hired a Head of Nomenclature—And You Might Want One, Too

Why Ford Hired a Head of Nomenclature—And You Might Want One, Too

October 10, 2026 0
How a Western Consumer Giant Is Thriving on China’s Social-Media Shoppers

How a Western Consumer Giant Is Thriving on China’s Social-Media Shoppers

October 10, 2026 0